I’d be more likely to think 1H 2022 at a SP of 40-50c after raising enough to get 5-6 drugs thru the clinic. MCAP north of a billion given the relative chance of success being about 55% for drug 1 (assuming all is going well at that time.) 3years till a billion earnings from RP drug at that stage and the discount relevant to the mcap expectations of say 5-10 B could get the SP much higher than that too.
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.27 |
Change
-0.025(1.93%) |
Mkt cap ! $737.8M | |||
| Open | High | Low | Value | Volume |
| $1.31 | $1.31 | $1.27 | $2.471M | 1.909M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 8032 | $1.26 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.27 | 3183 | 2 |
View Market Depth
| Last trade - 13.17pm 28/07/2025 (20 minute delay) ? |
| PYC (ASX) Chart |